⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IBRX News
ImmunityBio, Inc. Common Stock
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
accessnewswire.com
IBRX
Pomerantz LLP Advises Shareholders of Class Action Involving ImmunityBio, Inc. – IBRX
accessnewswire.com
IBRX
Bronstein, Gewirtz & Grossman LLC Urges ImmunityBio, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
IBRX
Bronstein, Gewirtz & Grossman, LLC Encourages ImmunityBio, Inc. (IBRX) Stockholders to Inquire about Securities Investigation
accessnewswire.com
IBRX
Pomerantz LLP Advises Shareholders of Class Action Against ImmunityBio, Inc. – IBRX
accessnewswire.com
IBRX
IBRX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that ImmunityBio, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
IBRX
Pomerantz LLP Advises Shareholders of Class Action Filing Involving ImmunityBio, Inc. – IBRX
accessnewswire.com
IBRX
ROSEN, THE FIRST FILING FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBRX
globenewswire.com
IBRX
Pomerantz LLP Advises of Securities Class Action Involving ImmunityBio, Inc. – IBRX
accessnewswire.com
IBRX
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages ImmunityBio, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by The Firm - IBRX
accessnewswire.com
IBRX